Horizon Pharma Plc (HZNP) SEC Filing 8-K Material Event for the period ending Wednesday, March 6, 2019

Horizon Pharma Plc

CIK: 1492426 Ticker: HZNP

View differences made from one to another to evaluate Horizon Pharma Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Horizon Pharma Plc.


Assess how Horizon Pharma Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Horizon Pharma Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Horizon Pharma Plc provided additional information to their SEC Filing as exhibits

Ticker: HZNP
CIK: 1492426
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-067447
Submitted to the SEC: Thu Mar 07 2019 5:19:33 PM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Wednesday, March 6, 2019
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: